Natural Inhibitors of P-glycoprotein in Acute Myeloid Leukemia.
P-glycoprotein
acute myeloid leukemia
multidrug resistance
natural substances
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
18 Feb 2023
18 Feb 2023
Historique:
received:
22
12
2022
revised:
15
02
2023
accepted:
16
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
3
3
2023
Statut:
epublish
Résumé
Acute myeloid leukemia (AML) remains an insidious neoplasm due to the percentage of patients who develop resistance to both classic chemotherapy and emerging drugs. Multidrug resistance (MDR) is a complex process determined by multiple mechanisms, and it is often caused by the overexpression of efflux pumps, the most important of which is P-glycoprotein (P-gp). This mini-review aims to examine the advantages of using natural substances as P-gp inhibitors, focusing on four molecules: phytol, curcumin, lupeol, and heptacosane, and their mechanism of action in AML.
Identifiants
pubmed: 36835550
pii: ijms24044140
doi: 10.3390/ijms24044140
pmc: PMC9962603
pii:
doi:
Substances chimiques
ATP Binding Cassette Transporter, Subfamily B, Member 1
0
Curcumin
IT942ZTH98
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Oncol Rep. 2004 Jan;11(1):133-6
pubmed: 14654915
Oncol Lett. 2015 Jan;9(1):177-182
pubmed: 25435954
Biomolecules. 2021 Jan 14;11(1):
pubmed: 33466926
Molecules. 2020 Mar 12;25(6):
pubmed: 32178481
Biomed Pharmacother. 2020 May;125:109885
pubmed: 32007917
Cancer Res. 2001 May 15;61(10):4030-7
pubmed: 11358822
PLoS One. 2012;7(8):e40720
pubmed: 22927901
Int J Mol Sci. 2020 Jul 13;21(14):
pubmed: 32668794
Br J Pharmacol. 2004 Dec;143(7):856-64
pubmed: 15504753
J Pharmacol Exp Ther. 2003 Dec;307(3):846-53
pubmed: 14534356
Eur J Pharmacol. 2018 Sep 5;834:188-196
pubmed: 30031797
Cancer Lett. 2008 Jan 18;259(1):111-8
pubmed: 18006147
Leukemia. 2019 Jan;33(1):64-74
pubmed: 29946192
J Enzyme Inhib Med Chem. 2016 Dec;31(6):867-81
pubmed: 26932198
Curr Drug Targets. 2015;16(14):1660-70
pubmed: 26028041
Int J Mol Sci. 2019 Feb 27;20(5):
pubmed: 30818786
J Ethnopharmacol. 2006 Jan 16;103(2):160-5
pubmed: 16169171
Blood Rev. 2019 Jul;36:70-87
pubmed: 31101526
Nat Prod Res. 2011 Aug;25(14):1339-46
pubmed: 21859258
Cancer Biol Ther. 2009 Sep;8(17):1632-9
pubmed: 19625778
Mini Rev Med Chem. 2021;21(17):2420-2457
pubmed: 33480345
Biochem Pharmacol. 2015 Feb 1;93(3):305-17
pubmed: 25543853
Phytomedicine. 2022 Mar 3;99:154012
pubmed: 35286936
Cancer Chemother Pharmacol. 2022 Feb;89(2):243-253
pubmed: 35066694
J Appl Biomed. 2020 Mar;18(1):18-25
pubmed: 34907704
Pharmaceuticals (Basel). 2022 Mar 15;15(3):
pubmed: 35337153
Front Immunol. 2022 Jan 05;12:791565
pubmed: 35069573
Biopharm Drug Dispos. 2011 May;32(4):245-51
pubmed: 21506134
PLoS One. 2013 Aug 15;8(8):e71071
pubmed: 23967153
Pharmaceuticals (Basel). 2019 Aug 26;12(3):
pubmed: 31454963
Recent Pat Biotechnol. 2014;8(3):194-205
pubmed: 27099143
Toxicol Lett. 2013 May 23;219(2):107-15
pubmed: 23470866
Crit Rev Oncol Hematol. 2021 Apr;160:103281
pubmed: 33667660
Nat Rev Cancer. 2002 Jan;2(1):48-58
pubmed: 11902585
Crit Rev Food Sci Nutr. 2021;61(6):946-958
pubmed: 32282223
Adv Exp Med Biol. 2007;595:471-80
pubmed: 17569225
Eur J Med Chem. 2021 Jan 15;210:113072
pubmed: 33310285
Pharmaceuticals (Basel). 2019 Oct 26;12(4):
pubmed: 31717764
Nat Prod Res. 2021 Nov;35(22):4494-4501
pubmed: 32178533
Clin Cancer Res. 2007 Apr 1;13(7):2236-45
pubmed: 17404108
Biomed Pharmacother. 2017 Jan;85:102-112
pubmed: 27930973
PLoS One. 2020 Oct 28;15(10):e0236460
pubmed: 33112882
Crit Rev Oncog. 2021;26(2):27-37
pubmed: 34347971
Chem Biol Interact. 2016 Jan 25;244:140-8
pubmed: 26689174
J Pharmacol Pharmacother. 2013 Apr;4(2):103-9
pubmed: 23761708
Nat Prod Commun. 2016 May;11(5):699-704
pubmed: 27319155
Ann N Y Acad Sci. 2009 Aug;1171:132-6
pubmed: 19723047
Oncol Rep. 2009 Sep;22(3):599-604
pubmed: 19639210
Proc Natl Acad Sci U S A. 1989 Jul;86(13):5128-32
pubmed: 2567994
Curr Med Chem. 2012;19(13):1946-2025
pubmed: 22257057
Toxicol Appl Pharmacol. 2005 Dec 1;209(2):167-73
pubmed: 15890377
Chem Biodivers. 2016 Oct;13(10):1369-1379
pubmed: 27447348
Molecules. 2019 Aug 13;24(16):
pubmed: 31412624
Life Sci. 2018 Dec 1;214:118-123
pubmed: 30449449
Adv Exp Med Biol. 2019;1141:549-580
pubmed: 31571174
Lancet Oncol. 2020 Sep;21(9):1201-1212
pubmed: 32791048
Eur J Pharmacol. 2010 Jan 25;626(2-3):139-45
pubmed: 19782062
Nutr Cancer. 2021;73(8):1520-1533
pubmed: 32700607
Front Oncol. 2021 Sep 16;11:706331
pubmed: 34604043
J Clin Oncol. 2020 Sep 10;38(26):2993-3002
pubmed: 32673171
Eur J Cancer Prev. 2020 Mar;29(2):191-200
pubmed: 31436750
Pharmaceuticals (Basel). 2021 Jan 31;14(2):
pubmed: 33572621
PLoS One. 2019 Mar 28;14(3):e0214594
pubmed: 30921428
Molecules. 2021 Nov 20;26(22):
pubmed: 34834102
Oncogene. 2004 Jul 1;23(30):5203-14
pubmed: 15122342
Antibiotics (Basel). 2022 Jan 20;11(2):
pubmed: 35203738
An Acad Bras Cienc. 2022 Mar 11;94(1):e20200851
pubmed: 35293512
Eur J Med Chem. 2019 Aug 15;176:268-291
pubmed: 31103904
Pharmaceuticals (Basel). 2016 Nov 10;9(4):
pubmed: 27834897
Acta Pharmacol Sin. 2009 Apr;30(4):451-7
pubmed: 19270722
Mol Med Rep. 2013 Jan;7(1):115-21
pubmed: 23023936
Food Chem Toxicol. 2018 Nov;121:82-94
pubmed: 30130593
Mol Med Rep. 2015 Jan;11(1):341-8
pubmed: 25339540
Jpn J Cancer Res. 2002 Feb;93(2):209-15
pubmed: 11856485
J Nat Prod. 2020 Apr 24;83(4):1107-1117
pubmed: 32091204
Cancer Res. 2007 Sep 15;67(18):8800-9
pubmed: 17875721
Antioxidants (Basel). 2022 Feb 28;11(3):
pubmed: 35326134
Biomed Chromatogr. 2021 Mar;35(3):e5005
pubmed: 33067801
Leukemia. 2019 Feb;33(2):379-389
pubmed: 30555165
Int J Mol Sci. 2021 Aug 27;22(17):
pubmed: 34502219
Curr Pharm Des. 2013;19(11):2047-69
pubmed: 23116312
Front Pharmacol. 2020 Sep 15;11:546439
pubmed: 33071779
Nutrients. 2021 Jun 10;13(6):
pubmed: 34200819
Lancet. 2012 Apr 21;379(9825):1508-16
pubmed: 22482940
Int J Mol Sci. 2022 Jun 13;23(12):
pubmed: 35743037
Biochem Pharmacol. 1994 Oct 7;48(7):1437-45
pubmed: 7945444
Molecules. 2017 May 25;22(6):
pubmed: 28587082
Planta Med. 2011 Jan;77(1):22-6
pubmed: 20645242
Pharmacol Res. 2021 Feb;164:105373
pubmed: 33316380
Cancer Res. 1993 Dec 15;53(24):5977-81
pubmed: 7903198
Biochem Cell Biol. 2020 Aug;98(4):484-491
pubmed: 31967866
Front Oncol. 2020 Oct 26;10:576559
pubmed: 33194688
Int J Oncol. 2014 Apr;44(4):1233-42
pubmed: 24535083
Microbiome. 2020 Apr 30;8(1):59
pubmed: 32354351
3 Biotech. 2020 Oct;10(10):451
pubmed: 33062579
Carcinogenesis. 2005 Nov;26(11):1956-64
pubmed: 15958516
Am J Physiol Gastrointest Liver Physiol. 2000 May;278(5):G693-9
pubmed: 10801261
Phytomedicine. 2018 Nov 15;50:184-195
pubmed: 30466977
Front Plant Sci. 2019 Mar 18;10:329
pubmed: 30936889
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jul 15;1121:58-65
pubmed: 31108322
R I Med J (2013). 2020 Apr 1;103(3):38-40
pubmed: 32236160
Bioorg Med Chem. 2008 Oct 15;16(20):9323-30
pubmed: 18824363
Pediatr Blood Cancer. 2018 Sep;65(9):e27089
pubmed: 29667722
Phytomedicine. 2013 Dec 15;21(1):47-61
pubmed: 23999162
Pharmacol Rep. 2020 Oct;72(5):1125-1151
pubmed: 32700248
Nat Rev Cancer. 2018 Jul;18(7):452-464
pubmed: 29643473
Fitoterapia. 2009 Jan;80(1):39-42
pubmed: 18940238
Annu Rev Pharmacol Toxicol. 1999;39:361-98
pubmed: 10331089
J Colloid Interface Sci. 2012 Sep 1;381(1):116-24
pubmed: 22682981
Bioorg Med Chem. 2017 Jan 15;25(2):581-596
pubmed: 27908756
Phytomedicine. 2008 Sep;15(9):754-8
pubmed: 18222670
Planta Med. 2003 Mar;69(3):235-40
pubmed: 12677527
J Cancer Res Clin Oncol. 2023 Jan;149(1):367-391
pubmed: 36269390
Adv Exp Med Biol. 2016;929:145-175
pubmed: 27771924
Biochem Pharmacol. 2002 Aug 15;64(4):573-82
pubmed: 12167476